Tag: equity
-
Diabetes Cell Therapy Biotech Acquired in $320M Deal
A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals.
-
Infographic – Q2 Venture Funds Decline Continues
Venture capital funds for North American technology start-ups continued their fall in the second quarter, with later-stage rounds showing the greatest drop.
-
Precision Microbial Resistance Joint Venture Formed
Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes.
-
Infographic – Biotech Index Continues Decline in Q2
A new look at the Nasdaq Biotechnology Index shows investors’ chill in biotech stocks begun earlier in the year continued into the second quarter of 2022.
-
Smell Detection Tech Company Raises $4M in Seed Funds
A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.
-
Infographic – Q1 Mental Health Tech Funds Drop
After a year of nearly constant gains in 2021, venture investments in digital mental health companies took a sharp drop in the first quarter of 2022.
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.
-
Life Science Investors Raise $1.1B for New Fund
A venture capital company specializing in health and life sciences start-up enterprises is raising $1.1 billion for a new investment fund.
-
GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.